Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients-Reference-Cited by-同舟云学术

Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients

Published:2006-05-23 Issue:2 Volume:56 Page:249-258
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Zippelius Alfred,Gati Asma,Bartnick Tammo,Walton Senta,Odermatt Bernhard,Jaeger Elke,Dummer Reinhold,Urosevic Mirjana,Filonenko Valeriy,Osanai Kazuhiro,Moch Holger,Chen Yao-Tseng,Old Lloyd J.,Knuth Alexander,Jaeger Dirk

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-006-0177-z.pdf

Reference32 articles.

1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28:235–242

2. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94:1914–1918

3. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137–148

4. Fensterle J, Becker JC, Potapenko T, Heimbach V, Vetter CS, Brocker EB, Rapp UR (2004) B-Raf specific antibody responses in melanoma patients. BMC Cancer 4:62

5. Fishman P, Merimski O, Baharav E, Shoenfeld Y (1997) Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo. Cancer 79:1461–1464

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RAB38 is a potential prognostic factor for tumor recurrence in non‑small cell lung cancer;Oncology Letters;2019-06-28

2. RAB38 promotes bladder cancer growth by promoting cell proliferation and motility;World Journal of Urology;2018-12-10

3. Rab38 Mutation and the Lung Phenotype;International Journal of Molecular Sciences;2018-07-27

4. Targeting Rabs as a novel therapeutic strategy for cancer therapy;Drug Discovery Today;2017-08

5. Immune response profiling of malignant pleural mesothelioma for diagnostic and prognostic biomarkers;Biomarkers;2016-03-24